25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2
et al., Nutrients, 12:5, 1–7, doi:10.3390/nu12051359
, 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients, 12:5, 1–7, doi:10.3390/nu12051359
Retrospective 107 patients in Switzerland showing lower vitamin D levels (11.1 ng/mL) in PCR positive patients compared with negative patients (24.6 ng/mL), p = 0.004.
D'Avolio et al., 9 May 2020, peer-reviewed, 8 authors.
25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2
Nutrients, doi:10.3390/nu12051359
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), with a clinical outcome ranging from mild to severe, including death. To date, it is unclear why some patients develop severe symptoms. Many authors have suggested the involvement of vitamin D in reducing the risk of infections; thus, we retrospectively investigated the 25-hydroxyvitamin D (25(OH)D) concentrations in plasma obtained from a cohort of patients from Switzerland. In this cohort, significantly lower 25(OH)D levels (p = 0.004) were found in PCR-positive for SARS-CoV-2 (median value 11.1 ng/mL) patients compared with negative patients (24.6 ng/mL); this was also confirmed by stratifying patients according to age >70 years. On the basis of this preliminary observation, vitamin D supplementation might be a useful measure to reduce the risk of infection. Randomized controlled trials and large population studies should be conducted to evaluate these recommendations and to confirm our preliminary observation.
Conflicts of Interest: The authors declare that they have no conflict of interest and no competing financial interests. Disclaimer: PHASE I AIFA, UNI EN ISO 9001 and 13485 Certificate Laboratory; Certificate No. IT-64386 and DM/17/154/S; Certification for: "Design, development and application of determination methods for clinical analytes and drugs, also with reference to in vitro dyagnostics. pharmacogenetic analyses." and "Design and development and application of quantification and detection methods of clinical analytes and drugs, finalized to the production of in vitro diagnostics" www.tdm-torino.org.
References
Arihiro, Nakashima, Matsuoka, Suto, Uchiyama et al., Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease, Inflamm. Bowel Dis, doi:10.1093/ibd/izy346
Fu, Wang, Yuan, Chen, Ao et al., Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis, J. Infect, doi:10.1016/j.jinf.2020.03.041
Grant, Lahore, Mcdonnell, Baggerly, French et al., Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients, doi:10.3390/nu12040988
Kakodkar, Kaka, Baig, A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19), Cureus, doi:10.7759/cureus.7560
Mccartney, Byrne, Optimisation of Vitamin D Status for Enhanced Immuno-protection Against Covid-19, Ir. Med. J
Molloy, Murphy, Vitamin, Covid-19 and Children, Ir. Med. J
Panarese, Shahini, Letter: Covid-19, and vitamin D, Aliment. Pharmacol. Ther, doi:10.1111/apt.15752
Loading..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.